Lendvai, N., Tsakos, I., Devlin, S. M., Schaffer, W. L., Hassoun, H., Lesokhin, A. M., . . . Landgren, O. (2018). Predictive biomarkers and practical considerations in the management of carflizomib-associated cardiotoxity. Leuk Lymphoma.
Citação norma ChicagoLendvai, Nikoletta, et al. "Predictive Biomarkers and Practical Considerations in the Management of Carflizomib-associated Cardiotoxity." Leuk Lymphoma 2018.
MLA citiranjeLendvai, Nikoletta, et al. "Predictive Biomarkers and Practical Considerations in the Management of Carflizomib-associated Cardiotoxity." Leuk Lymphoma 2018.
Opozorilo: Ti citati niso vedno 100% točni.